27th National Clinical Education Symposium Presentation Abstracts

Actions for Presentation


Download PDF Back to list

Other presentations


Postpartum Psychosis Following Eclampsia: Early Follow-Up of a Case - Page 134
Alperen Kanıvar, Ayse Erguner Aral, Esin Erdogan

Bipolar Disorder Type II Depressive Episode and Anorexia Nervosa Restrictive Type Comorbidity: A Case of Recurrent Suicide Attempts - Page 135
Munise Dinçarslan, Ayse Erguner Aral, Esin Erdoğan

Behavioral Variant of Alzheimer's Disease: An Atypical Case Supported by CSF Biomarkers - Page 136
Koray Hamza Cihan, Kübra Özçelik, Kazım Cihan Can, Erguvan Tuğba Özel Kızıl

A Case Study: Myositis Due To Clozapine Use - Page 137
Mehmet Eren Yaşaran, Soner Akar, Cansu Bak, Aslıhan Özdemir Yaşaran, Figen Ünal Demir

The Efficacy of Aripiprazole in Managing Tourette Syndrome with Comorbid OCD and Mood Disorders: A Case Study - Page 138
Damla Aslan Kirazoğlu, Cansu Çakır Şen, Elif Şevval Uzun, Nesrin Buket Tomruk

Manic Shift Triggered by Escitalopram in an Elderly Patient with Long-Term Mood Stability - Page 139
İnci Timur, Tuba Ülkevan

28 APRIL 2025, MONDAY
13:00-14:00 POSTER PRESENTATION SESSION-1

Early-onset Psychosis following methylphenidate use in a patient with ADHD diagnosis

Merve Sena Kırmacı1

1. Aydın Adnan Menderes University


DOI: 10.5080/kes27.abs107 Page 133
OBJECTIVE:Methylphenidate is widely used in the treatment of Attention-deficit and hyperactivity disorder(ADHD). However, it is known to cause psychotic symptoms even at therapeutic doses. Furthermore, diagnostic confusion can arise due to the overlap in symptoms between ADHD and schizophrenia. This case report discusses a patient who was previously diagnosed with ADHD, treated with methylphenidate, and subsequently experienced recurrent psychotic episodes. Written and verbal informed consent was obtained from the patient. CASE (The patient consent must be provided and specified with appropriate terms.):A 27-year-old male patient was admitted to our inpatient unit with hallucinations, delusions, and disorganized behavior. Upon admission, he presented with irritability and euphoria The patient’s first psychiatric consultation occurred in 2012, at a child psychiatry clinic, due to hyperactivity and inappropriate behaviors. He was diagnosed with ADHD and started on methylphenidate. However, he never achieved full remission. In 2015, he experienced his first psychotic episode and was diagnosed with atypical psychosis. Since 2016, he has had four psychiatric hospitalizations due to recurrent psychotic episodes and was treated with various antipsychotics, both as an inpatient and outpatient. In 2024, he was admitted to our unit again due to a psychotic episode. DISCUSSION:Studies have shown that ADHD is the most frequent comorbid condition in children and adolescents with schizophrenia. The neuropsychological changes hypothesized for these two disorders partially overlap, leading to diagnostic confusion in early stages. Methylphenidate, a commonly used medication in ADHD treatment, requires careful consideration. Its effects on the brain are similar to those of cocaine, as it rapidly penetrates the brain and stimulates dopamine release. Dopamine plays a significant role in the development of psychosis. In summary, ADHD should be diagnosed with caution, particularly in childhood, and medication choices should be made with sensitivity. For mild to moderate cases, alternative medication options should be considered before initiating psychostimulants.